Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta‐analysis of disease progression rates in recent multicenter clinical trials
Craig M. McDonald, Gautam Sajeev, Zhiwen Yao, et al.
Muscle & Nerve (2019) Vol. 61, Iss. 1, pp. 26-35
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Duchenne muscular dystrophy
Dongsheng Duan, Nathalie Goemans, Shin’ichi Takeda, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 830
Emerging therapies for Duchenne muscular dystrophy
Theodora Markati, Maryam Oskoui, Michelle A. Farrar, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 9, pp. 814-829
Closed Access | Times Cited: 76
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Addeli Bez Batti Angulski, Nora Hosny, Houda Cohen, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 71
Duchenne muscular dystrophy: Current treatment and emerging exon skipping and gene therapy approach
Grant Patterson, Haley Conner, Mecham Groneman, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175675-175675
Closed Access | Times Cited: 43
Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
Mattia Quattrocelli, Aaron S. Zelikovich, Isabella M. Salamone, et al.
Journal of Neuromuscular Diseases (2020) Vol. 8, Iss. 1, pp. 39-52
Open Access | Times Cited: 59
Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy
W. Douglas Biggar, Andrew J. Skalsky, Craig M. McDonald
Journal of Neuromuscular Diseases (2022) Vol. 9, Iss. 4, pp. 463-476
Open Access | Times Cited: 30
Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center
Jessica R. Marden, Jonathan Freimark, Zhiwen Yao, et al.
Journal of Comparative Effectiveness Research (2020) Vol. 9, Iss. 3, pp. 177-189
Open Access | Times Cited: 40
A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment
Olga Mitelman, Hoda Abdel‐Hamid, Barry J. Byrne, et al.
Journal of Neuromuscular Diseases (2021) Vol. 9, Iss. 1, pp. 39-52
Open Access | Times Cited: 38
Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis
Nermina Ferizović, Jessica J. Summers, Igor Beitia Ortiz de Zárate, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0265879-e0265879
Open Access | Times Cited: 23
Cardiorespiratory Progression Over 5 Years and Role of Corticosteroids in Duchenne Muscular Dystrophy
Federica Trucco, Joana Domingos, Chee Geap Tay, et al.
CHEST Journal (2020) Vol. 158, Iss. 4, pp. 1606-1616
Closed Access | Times Cited: 39
Therapeutic Approaches for Duchenne Muscular Dystrophy: Old and New
Samuel Mackenzie, Stefan Nicolau, Anne M. Connolly, et al.
Seminars in Pediatric Neurology (2021) Vol. 37, pp. 100877-100877
Closed Access | Times Cited: 28
Safety and Tolerability of Wharton’s Jelly-Derived Mesenchymal Stem Cells for Patients With Duchenne Muscular Dystrophy: A Phase 1 Clinical Study
Jiwon Lee, Sang Eon Park, Mi‐Ra Kim, et al.
Journal of Clinical Neurology (2025) Vol. 21, Iss. 1, pp. 40-40
Open Access
Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin−/−/Utrophin−/− Double-Knockout Mice
Xueqin Gao, Yan Cui, Greg Zhang, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 116-116
Open Access
The latest developments in synthetic approaches to duchenne muscular dystrophy
Lucy M. Johnson, Tariq G. Pulskamp, Daniel J. Berlau
Expert Review of Neurotherapeutics (2025)
Closed Access
Uso de glucocorticoides en pacientes con distrofia muscular de Duchenne
Edna Julieth Bobadilla-Quesada, Juan David Lasprilla Tovar, Norma Carolina Barajas Viracachá, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-19
Open Access
Glucocorticoides y manejo cardíaco en pacientes con distrofia muscular de Duchenne
Edna Julieth Bobadilla-Quesada, Manuel Huertas-Quiñones, Juan David Lasprilla Tovar, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-13
Open Access
Human Dystrophin Expressing Chimeric (DEC) Cell Therapy Ameliorates Cardiac, Respiratory, and Skeletal Muscle's Function in Duchenne Muscular Dystrophy
Maria Siemionow, Paulina Langa, Michał Harasymczuk, et al.
Stem Cells Translational Medicine (2021) Vol. 10, Iss. 10, pp. 1406-1418
Open Access | Times Cited: 22
Prognostic factors, disease course, and treatment efficacy in Duchenne muscular dystrophy: A systematic review and meta‐analysis
Fabio José Weber, Tsogyal D. Latshang, Manuel R. Blum, et al.
Muscle & Nerve (2022) Vol. 66, Iss. 4, pp. 462-470
Open Access | Times Cited: 16
Update of the Brazilian consensus recommendations on Duchenne muscular dystrophy
Alexandra Prufer de Queiroz Campos Araújo, Jonas Alex Morales Saute, Clarisse Pereira Dias Drumond Fortes, et al.
Arquivos de Neuro-Psiquiatria (2023) Vol. 81, Iss. 01, pp. 081-094
Open Access | Times Cited: 9
Comparison of pharmaceutical properties and biological activities of prednisolone, deflazacort, and vamorolone in DMD disease models
Grace Liu, Philip Lipari, Anna Mollin, et al.
Human Molecular Genetics (2023) Vol. 33, Iss. 3, pp. 211-223
Open Access | Times Cited: 9
Quantifying Variability in Motor Function in Duchenne Muscular Dystrophy: UK Centiles for the NorthStar Ambulatory Assessment, 10 m Walk Run Velocity and Rise from Floor Velocity in GC Treated Boys
Georgia Stimpson, Deborah Ridout, Amy Wolfe, et al.
Journal of Neuromuscular Diseases (2023) Vol. 11, Iss. 1, pp. 153-166
Open Access | Times Cited: 9
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease
Craig M. McDonald, Eric Camino, Rafael Escandon, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 499-523
Open Access | Times Cited: 3
Relationship between growth and ambulation loss in Duchenne muscular dystrophy boys on steroids
Georgia Stimpson, Deborah Ridout, Anna Sárközy, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 12
Open Access | Times Cited: 3
Gene doping and genomic science in sports: where are we?
Sheila López, João Luiz de Meirelles, Vanessa Rayol, et al.
Bioanalysis (2020) Vol. 12, Iss. 11, pp. 801-811
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top